ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
Fyfee
|
106 |
31K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
106
|
31K
|
0
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.2M |
8 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
21K
|
7.2M
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Dr Daniel Tillett appointed CEO of Race Oncology
|
|
Fyfee
|
120 |
33K |
3 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
120
|
33K
|
3
|
|
ASX - By Stock
|
EMR |
Re:
Owning gold or gold mine
|
|
Fyfee
|
20 |
6.2K |
6 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
20
|
6.2K
|
6
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Emerald Now Owns 100% of Bullseye
|
|
Fyfee
|
6 |
2.6K |
2 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
6
|
2.6K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
Fyfee
|
106 |
31K |
7 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
106
|
31K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
Fyfee
|
1.0K |
290K |
6 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
1.0K
|
290K
|
6
|
|
ASX - By Stock
|
EMR |
Re:
Relaxed share holders
|
|
Fyfee
|
44 |
15K |
4 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
44
|
15K
|
4
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Mount Hope Sub-Blocks and Tick Hill Transactions Complete
|
|
Fyfee
|
46 |
13K |
1 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
46
|
13K
|
1
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Exploration Update - Drilling Recommences
|
|
Fyfee
|
177 |
71K |
8 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
177
|
71K
|
8
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Top 20 Holders and Distribution Schedule
|
|
Fyfee
|
7 |
2.9K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
7
|
2.9K
|
0
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Top 20 Holders and Distribution Schedule
|
|
Fyfee
|
7 |
2.9K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
7
|
2.9K
|
2
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Application for quotation of securities - EMR
|
|
Fyfee
|
3 |
1.4K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
3
|
1.4K
|
5
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Quarterly Report
|
|
Fyfee
|
12 |
4.8K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
12
|
4.8K
|
2
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Quarterly Report
|
|
Fyfee
|
12 |
4.8K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
12
|
4.8K
|
3
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Emerald Proceeds to Compulsory Acquisition of Bullseye
|
|
Fyfee
|
5 |
1.9K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
5
|
1.9K
|
1
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Significant Exploration Results Continue at Emerald Projects
|
|
Fyfee
|
10 |
4.2K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
10
|
4.2K
|
7
|
|
ASX - By Stock
|
CAI |
Re:
Gold price
|
|
Fyfee
|
134 |
45K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
134
|
45K
|
1
|
|
ASX - By Stock
|
RRL |
Re:
Ann: Amended Trading Halt
|
|
Fyfee
|
25 |
16K |
3 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
25
|
16K
|
3
|
|
ASX - By Stock
|
AAR |
Re:
Ann: Trading Halt
|
|
Fyfee
|
10 |
2.8K |
9 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
10
|
2.8K
|
9
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Emerald's Growth Strategy Underpinned by Okvau Excellence
|
|
Fyfee
|
53 |
18K |
2 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
53
|
18K
|
2
|
|
ASX - By Stock
|
CNB |
Re:
Ann: High Grade Discovery 4m @ 7.0% Cu - Exploration Update
|
|
Fyfee
|
373 |
149K |
2 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
373
|
149K
|
2
|
|
ASX - By Stock
|
CNB |
Re:
Ann: High Grade Discovery 4m @ 7.0% Cu - Exploration Update
|
|
Fyfee
|
373 |
149K |
6 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
373
|
149K
|
6
|
|
ASX - By Stock
|
CNB |
Re:
Ann: High Grade Discovery 4m @ 7.0% Cu - Exploration Update
|
|
Fyfee
|
373 |
149K |
16 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
373
|
149K
|
16
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Significant Exploration Results Continue at EMR Prospects
|
|
Fyfee
|
14 |
6.2K |
5 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
14
|
6.2K
|
5
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Significant Exploration Results Continue at EMR Prospects
|
|
Fyfee
|
14 |
6.2K |
8 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
14
|
6.2K
|
8
|
|
ASX - By Stock
|
EMR |
Re:
Memot
|
|
Fyfee
|
17 |
5.3K |
2 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
17
|
5.3K
|
2
|
|
ASX - By Stock
|
EMR |
Re:
Just made my first sale of EMR
|
|
Fyfee
|
31 |
8.7K |
1 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
31
|
8.7K
|
1
|
|
ASX - By Stock
|
EMR |
Re:
Just made my first sale of EMR
|
|
Fyfee
|
31 |
8.7K |
0 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
31
|
8.7K
|
0
|
|
ASX - By Stock
|
EMR |
Re:
Just made my first sale of EMR
|
|
Fyfee
|
31 |
8.7K |
3 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
31
|
8.7K
|
3
|
|
ASX - By Stock
|
EMR |
Re:
Just made my first sale of EMR
|
|
Fyfee
|
31 |
8.7K |
0 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
31
|
8.7K
|
0
|
|
ASX - By Stock
|
EMR |
Re:
Just made my first sale of EMR
|
|
Fyfee
|
31 |
8.7K |
3 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
31
|
8.7K
|
3
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Application for quotation of securities - EMR
|
|
Fyfee
|
11 |
3.0K |
4 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
11
|
3.0K
|
4
|
|
ASX - By Stock
|
DLI |
Re:
Flano - Lost then found
|
|
Fyfee
|
3 |
1.1K |
3 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
3
|
1.1K
|
3
|
|
ASX - By Stock
|
DLI |
Re:
Flano - Lost then found
|
|
Fyfee
|
3 |
1.1K |
0 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
3
|
1.1K
|
0
|
|
ASX - By Stock
|
DLI |
Re:
Flano - Lost then found
|
|
Fyfee
|
3 |
1.1K |
0 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
3
|
1.1K
|
0
|
|
ASX - By Stock
|
DLI |
Flano - Lost then found
|
|
Fyfee
|
3 |
1.1K |
0 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
3
|
1.1K
|
0
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Change of Director's Interest Notice
|
|
Fyfee
|
6 |
2.8K |
9 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
6
|
2.8K
|
9
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Change of Director's Interest Notice
|
|
Fyfee
|
6 |
2.8K |
7 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
6
|
2.8K
|
7
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Change of Director's Interest Notice
|
|
Fyfee
|
6 |
2.8K |
6 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
6
|
2.8K
|
6
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Fyfee
|
10K |
3.8M |
7 |
28/11/23 |
28/11/23 |
General
|
10K
|
3.8M
|
7
|
|
ASX - By Stock
|
DLI |
Re:
Delta Lithium General Discussion
|
|
Fyfee
|
2.3K |
932K |
3 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
2.3K
|
932K
|
3
|
|
ASX - By Stock
|
TG6 |
Re:
Ann: Trading Halt
|
|
Fyfee
|
207 |
55K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
207
|
55K
|
1
|
|
ASX - By Stock
|
TG6 |
Re:
Ann: Trading Halt
|
|
Fyfee
|
207 |
55K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
207
|
55K
|
1
|
|
ASX - By Stock
|
TG6 |
Re:
Ann: Trading Halt
|
|
Fyfee
|
207 |
55K |
6 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
207
|
55K
|
6
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Greater Duchess Chalcus Lode Extension 87m @ 2.3% Cu
|
|
Fyfee
|
112 |
42K |
7 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
112
|
42K
|
7
|
|
ASX - By Stock
|
EMR |
Re:
Ann: InvoCare Limited to be removed from the S&P/ASX 200 Index
|
|
Fyfee
|
37 |
13K |
4 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
37
|
13K
|
4
|
|
ASX - By Stock
|
CNB |
Re:
Ann: 2023 AGM Presentation
|
|
Fyfee
|
81 |
25K |
66 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
81
|
25K
|
66
|
|
ASX - By Stock
|
CNB |
Re:
Ann: 2023 AGM Presentation
|
|
Fyfee
|
81 |
25K |
16 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
81
|
25K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Fyfee
|
231 |
66K |
5 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
231
|
66K
|
5
|
|